Because ERK2, JNK2, and p38 are enzymes, compounds serving as enzyme inhibitors are more likely to inhibit ERK2, JNK2, and p38 and exert anti-osteoarthritis effect. The gene discussed is MAPK9; the disease is osteoarthritis.